{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T05:18:51Z","timestamp":1740547131423,"version":"3.38.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.ejphar.2010.08.012","type":"journal-article","created":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T09:14:20Z","timestamp":1283332460000},"page":"62-67","source":"Crossref","is-referenced-by-count":8,"title":["SA14867, a newly synthesized kappa-opioid receptor agonist with antinociceptive and antipruritic effects"],"prefix":"10.1016","volume":"647","author":[{"given":"Yaeko","family":"Tsukahara-Ohsumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumio","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Niwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikiko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Sasano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Aono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2010.08.012_bb0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1744-8069-6-8","article-title":"Trigeminal injury causes kappa opioid-dependent allodynic, glial and immune cell responses in mice","volume":"6","author":"Aida","year":"2010","journal-title":"Mol. Pain"},{"key":"10.1016\/j.ejphar.2010.08.012_bb0010","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1517\/13543784.6.10.1351","article-title":"Novel developments with selective, non-peptidic kappa-opioid receptor agonist","volume":"6","author":"Barber","year":"1997","journal-title":"Exp. Opin. Invest. Drugs"},{"key":"10.1016\/j.ejphar.2010.08.012_bb0015","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1365-2982.2008.01183.x","article-title":"Novel pharmacology: asimadoline, a \u03ba-opioid agonist, and visceral sensation","volume":"20","author":"Camilleri","year":"2008","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.ejphar.2010.08.012_bb0020","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2165\/00003088-200443130-00004","article-title":"Clinical Pharmacology of tramadol","volume":"43","author":"Grond","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2010.08.012_bb0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuroscience.2009.06.016","article-title":"Nalfurafine prevents 5'-guanidinonaltrindole- and compound 48\/80-induced spinal c-fos expression and attenuates 5'-guanidinonaltrindole-elicited scratching behavior in mice","volume":"163","author":"Inan","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2010.08.012_bb0030","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00213-010-1803-1","article-title":"Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse","volume":"210","author":"Jackson","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2010.08.012_bb0035","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0014-2999(94)00780-B","article-title":"Scratching behavior induced by pruritogenic but not algesiogenic agents in mice","volume":"275","author":"Kuraishi","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.08.012_bb0040","first-page":"2102","article-title":"The analgesic activity of imidazopyridine derivatives","volume":"28","author":"Maruyama","year":"1978","journal-title":"Arzneim. Forsch."},{"key":"10.1016\/j.ejphar.2010.08.012_bb0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pbb.2005.12.011","article-title":"Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist","volume":"83","author":"McCurdy","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2010.08.012_bb0050","doi-asserted-by":"crossref","first-page":"13525","DOI":"10.1073\/pnas.0705924104","article-title":"TRPA1 mediates formalin-induced pain","volume":"104","author":"McNamara","year":"2007","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2010.08.012_bb0055","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1139\/y04-027","article-title":"Synergy between the antinociceptive affects of morphine and NSAIDs","volume":"82","author":"Miranda","year":"2004","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.08.012_bb0060","first-page":"1555","article-title":"The pharmacological profile of 2-(8-methyl-10, 11-dihydro-11-oxodibenz[b, f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity","volume":"33","author":"Nakamura","year":"1983","journal-title":"Arzneim. Forsch."},{"key":"10.1016\/j.ejphar.2010.08.012_bb0065","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1523\/JNEUROSCI.5392-07.2008","article-title":"Phosphatidylinositol 3-kinase is a key mediator of central sensitization in painful inflammatory conditions","volume":"28","author":"Pezet","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2010.08.012_bb0070","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1358\/dnp.2008.21.10.1314057","article-title":"Chronic pruritus: targets, mechanisms and future therapies","volume":"21","author":"Pogatzki-Zahn","year":"2008","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.ejphar.2010.08.012_bb0075","series-title":"Drug Development, Molecular Targets for GI Diseases","first-page":"203","article-title":"Opioid receptors, targets for new gastrointestinal drug development","author":"Revi\u00e8re","year":"2000"},{"key":"10.1016\/j.ejphar.2010.08.012_bb0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.coph.2008.12.009","article-title":"Peripheral mechanisms of opioid analgesia","volume":"9","author":"Stein","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.08.012_bb0085","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0014-2999(01)01588-6","article-title":"Antipruritic activity of the \u03ba-opioid receptor agonist, TRK-820","volume":"435","author":"Togashi","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.08.012_bb0090","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1248\/bpb.33.1050","article-title":"Role of leukotriene B4 in 5-lipoxygenase metabolite and allergy-induced itch-associated responses in mice","volume":"33","author":"Tsuji","year":"2010","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejphar.2010.08.012_bb0095","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1016\/j.lfs.2004.05.033","article-title":"Inhibitory effects of TRK-820 on systemic skin scratching induced by morphine in rhesus monkeys","volume":"75","author":"Wakasa","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2010.08.012_bb0100","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1681\/ASN.2005020152","article-title":"Kappa-opioid system in uremic pruritus: Multicenter, randomized, double-blinded placebo-controlled clinical studies","volume":"16","author":"Wikstr\u00f6m","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2010.08.012_bb0105","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0022-3565(24)36877-6","article-title":"Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTP\u03b3S binding to membranes: determination of potencies and efficacies of ligands","volume":"282","author":"Zhu","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299910008149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299910008149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T09:27:21Z","timestamp":1740475641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299910008149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":21,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0014299910008149"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2010.08.012","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}